Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 03, 2023 08:00 ET | Source: T2 Biosystems, Inc.

T2 Biosystems to Report Fourth Quarter and Full Year 2022 Financial Results on March 13, 2023

LEXINGTON, Mass., March 03, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today...
February 15, 2023 07:30 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces Pricing of $12 Million Public Offering

LEXINGTON, Mass., Feb. 15, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO) today announced the pricing of its previously announced underwritten public offering of 11,111,111 shares of...
February 13, 2023 16:19 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces Proposed Public Offering

LEXINGTON, Mass., Feb. 13, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO) today announced that it is commencing an underwritten public offering of shares of its common stock (or common...
February 13, 2023 16:01 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces Positive Results upon Completion of U.S. Clinical Evaluation for the T2Biothreat Panel

LEXINGTON, Mass., Feb. 13, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced...
February 06, 2023 16:05 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Advances to the Phase 2 in HHS and the Steven and Alexandra Cohen Foundation’s LymeX Diagnostics Prize

LEXINGTON, Mass., Feb. 06, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today...
February 03, 2023 16:30 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Reports Granting of Inducement Award

LEXINGTON, Mass., Feb. 03, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens, and antibiotic resistance genes, announced today...
January 23, 2023 16:30 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2022 Financial Results

LEXINGTON, Mass., Jan. 23, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced...
December 28, 2022 09:00 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces Extension of Multiyear Innovative Technology Contract with Vizient, Inc.

LEXINGTON, Mass., Dec. 28, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced...
December 08, 2022 08:28 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Highlights Peer-Reviewed Article Linking COVID-19 and Sepsis and Underscoring CDC Call for Adoption of Early and Accurate Microbial Diagnosis to Guide Targeted Initial Antimicrobial Therapy

LEXINGTON, Mass., Dec. 08, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, today announced the...
November 10, 2022 16:05 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces Third Quarter 2022 Financial Results

LEXINGTON, Mass., Nov. 10, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes,...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right